CCOP - Michigan Cancer Research Consortium
Claim this profile,
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Prostate Cancer
355 reported clinical trials
38 medical researchers
Summary
CCOP - Michigan Cancer Research Consortium is a medical facility located in undefined, undefined. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Recurrence, Prostate Cancer and other specialties. CCOP - Michigan Cancer Research Consortium is involved with conducting 355 clinical trials across 376 conditions. There are 38 research doctors associated with this hospital, such as Tareq Al Baghdadi, Elie G. Dib, Samir Narayan, and Paul Swiecicki.Area of expertise
1Breast Cancer
Global LeaderER positive
Stage III
Stage II
2Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Tareq Al BaghdadiSaint Joseph Mercy Hospital7 years of reported clinical research
Expert in Cancer
Expert in Tumors
69 reported clinical trials
127 drugs studied
Elie G. DibSaint Joseph Mercy Hospital4 years of reported clinical research
Expert in Cancer
Studies Multiple Myeloma
34 reported clinical trials
94 drugs studied
Samir NarayanSaint Joseph Mercy Hospital2 years of reported clinical research
Expert in Cancer
Studies Prostate Cancer
26 reported clinical trials
70 drugs studied
Paul SwiecickiUniversity of Michigan Comprehensive Cancer Center1 year of reported clinical research
Expert in Cancer
Studies Melanoma
19 reported clinical trials
29 drugs studied
Clinical Trials running at CCOP - Michigan Cancer Research Consortium
Prostate Cancer
Cancer
Breast Cancer
Liver Cancer
Tumors
Hepatocellular Carcinoma
Glioblastoma
Renal Cell Carcinoma
Oropharyngeal Cancer
Kidney Cancer
Combination Therapy
for Metastatic Prostate Cancer
This study is evaluating whether radiation therapy with hormone therapy (ADT) and chemotherapy is safe and effective for men with prostate cancer.
Recruiting3 awards Phase 2
Moderate vs Ultra-Hypofractionated Radiation
for Prostate Cancer
This study is evaluating whether ultra-hypofractionated radiation therapy is better than moderately hypofractionated radiation therapy for prostate cancer.
Recruiting1 award Phase 2
Talazoparib + Belinostat
for Metastatic Cancer
This study is evaluating whether a combination of a PARP inhibitor and a HDAC inhibitor is safe and tolerable.
Recruiting1 award Phase 114 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at CCOP - Michigan Cancer Research Consortium?
CCOP - Michigan Cancer Research Consortium is a medical facility located in undefined, undefined. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Recurrence, Prostate Cancer and other specialties. CCOP - Michigan Cancer Research Consortium is involved with conducting 355 clinical trials across 376 conditions. There are 38 research doctors associated with this hospital, such as Tareq Al Baghdadi, Elie G. Dib, Samir Narayan, and Paul Swiecicki.